Cell-free DNA methylation as a predictive biomarker of response to neoadjuvant chemotherapy for patients with muscle invasive bladder cancer in SWOG S1314. Cell-free DNA methylation as a predictive biomarker of response to neoadjuvant chemotherapy for patients with muscle invasive bladder cancer in SWOG S1314
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
cfDNA methylation analysis to predict cisplatin treatment response in bladder cancer Overall design: cfDNA was collected from 72 patients in SWOG S1314 before neoadjuvant chemotherapy and was analyzed using EPIC microarray.
创建时间：
2022-01-07
